Therdose Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 28-06-2024
- Paid Up Capital ₹ 9.99 Cr
as on 28-06-2024
- Company Age 21 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.58 Cr
as on 28-06-2024
- Satisfied Charges ₹ 24.13 Cr
as on 28-06-2024
- Revenue 68.76%
(FY 2022)
- Profit 133.94%
(FY 2022)
- Ebitda 146.60%
(FY 2022)
- Net Worth 210.85%
(FY 2022)
- Total Assets -20.74%
(FY 2022)
About Therdose Pharma
The Corporate was formerly known as Oshadha Therapeutics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.99 Cr.
The company currently has active open charges totaling ₹11.58 Cr. The company has closed loans amounting to ₹24.13 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Therdose Pharma Private Limited India is Kumar Madasa as CEO. Ratna Imadabathuni, Raja Imadabathuni, Mantena Narasa, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PTC042272
- Company No.
042272
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2003
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Therdose Pharma Private Limited offer?
Therdose Pharma Private Limited offers a wide range of products and services, including Reference Books, Technology Books.
Who are the key members and board of directors at Therdose Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ratna Imadabathuni  | Managing Director | 12-Nov-2021 | Current |
| Kumar Madasa | CEO | 06-Feb-2020 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raja Imadabathuni | Director | 03-Oct-2022 | Current |
Mantena Narasa  | Director | 26-Nov-2021 | Current |
| Meka Rao | Director | 26-Nov-2021 | Current |
| Arvind Panyala | Director | 26-Nov-2021 | Current |
| Mahindra Imadabathuni | Whole-Time Director | 26-Nov-2021 | Current |
Financial Performance of Therdose Pharma.
Therdose Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 68.76% increase. The company also saw a substantial improvement in profitability, with a 133.94% increase in profit. The company's net worth Soared by an impressive increase of 210.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Therdose Pharma?
In 2022, Therdose Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vance And Health Pharmaceuticals Private LimitedActive 25 years 10 monthsRatna Imadabathuni, Raja Imadabathuni and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Dec 2022 | ₹11.58 Cr | Open |
Axis Bank Limited Creation Date: 06 May 2022 | ₹2.57 M | Satisfied |
Others Creation Date: 31 Jul 2018 | ₹5.88 M | Satisfied |
How Many Employees Work at Therdose Pharma?
Therdose Pharma has a workforce of 137 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Therdose Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Therdose Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
